文献速递产科麻醉区域麻醉与超声疼痛医学

鞘内吗啡用于剖宫产临床实践的实施及其对患者报告恢复质量的影响:单中心队列研究

The implementation of intrathecal morphine for caesarean delivery into clinical practice, and assessment of its impact on patient-reported quality of recovery using the ObsQoR-10-Dutch scale: A single-centre cohort study.
PubMed 文献 · Eur J Anaesthesiol · 2025-01-29

荷兰单中心前后对照研究评估剖宫产鞘内吗啡(ITM)实施对恢复质量的影响。实施前55例接受静脉吗啡镇痛或硬膜外延续,实施后47例接受ITM 100 μg及按需口服吗啡。结果ObsQoR-10评分提高9.0分(95%CI 3.1-15,P=0.002),多变量分析提高6.3分(95%CI 0.37-12.2),未达预设临床相关阈值,但自评健康、住院时间和阿片消耗改善。

要点

  • ITM实施后ObsQoR-10恢复质量评分显著提高,但多变量校正后未达临床相关阈值。
  • ITM组阿片消耗中位数降至0 mg,住院时间缩短,自评健康评分提高。
  • 非随机设计需谨慎解读,结果支持ITM用于剖宫产多模式镇痛策略。

核心结论

  • 剖宫产实施ITM带来中等程度的产科恢复改善并减少阿片消耗,非随机设计需谨慎解读,支持ITM用于多模式镇痛策略。

研究设计与样本

  • 单中心观察性前后对照研究,荷兰三级大学医院2023年1月至2024年4月,纳入椎管内麻醉下剖宫产患者,实施前组55例,实施后组47例。

主要发现

  • ITM方案依从性为98%。
  • ObsQoR-10评分实施前65±16 vs 实施后74±13分,平均差9.0(95%CI 3.1-15)分,P=0.002,疼痛评分、身体舒适度、独立性和心理幸福感改善。
  • 多变量分析改善6.3(95%CI 0.37-12.2)分,有统计学意义但未达预设临床相关阈值。
  • 自评健康评分57±18 vs 68±17,P=0.002;住院时间中位数41(36-51) vs 37(32-49)h,P=0.032;阿片消耗中位数52(35-73) vs 0(0-0)mg,P<0.001。

关键数值与推荐

  • 实施后组接受ITM 100 μg及按需口服吗啡片10 mg。
  • 主要结局为ObsQoR-10-Dutch问卷评分(0-100分)。
  • 实施前组接受静脉吗啡患者自控镇痛或延续产程中硬膜外镇痛。

临床怎么用

  • 剖宫产椎管内麻醉下可考虑ITM 100 μg联合按需口服吗啡作为多模式镇痛策略,以改善恢复质量并减少阿片消耗。

局限性

  • 非随机前后对照设计,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimising a mother's quality of recovery following caesarean delivery is of paramount importance as it facilitates maternal care of the newborn and affects physical, psychological and emotional well being. Intrathecal morphine (ITM) reduces postoperative pain and may improve quality of recovery: however its widespread use is limited. OBJECTIVE: To assess the effects of implementing ITM for caesarean delivery on postoperative quality of recovery. STUDY DESIGN: Single-centre observational before-after study. SETTING: Tertiary university hospital, the Netherlands, January 2023 until April 2024. STUDY POPULATION: Patients who underwent caesarean delivery under spinal anaesthesia. INTERVENTION: Patients recruited before implementation of ITM ( n = 55) received patient-controlled intravenous analgesia with morphine or continuation of epidural analgesia previously used for labour ('pre-ITM group'). Patients recruited after implementation of ITM ( n = 47) received ITM 100 μg and oral morphine tablets 10 mg as needed ('ITM group'). OUTCOMES: Primary outcome was the score on the Obstetric Quality of Recovery (ObsQoR-10-Dutch) questionnaire (0 to 100). Secondary outcomes included ObsQoR-10 subscores, length of stay, opioid consumption and self-reported general health score (0 to 100). RESULTS: Protocol adherence for ITM was 98%. Quality of recovery improved significantly [ObsQoR-10 scores pre-ITM 65 ± 16 vs. ITM 74 ± 13 points, mean difference 9.0 (95% CI, 3.1 to 15] points, P = 0.002], with improvement in pain scores, physical comfort, independence and psychological wellbeing. In multivariate analysis, the improvement was 6.3 (95% CI, 0.37 to 12.2] points, which was statistically significant but did not reach the predefined threshold for clinical relevance. There was, however, an improvement in self-reported general health score (57 ± 18 vs. 68 ± 17, P = 0.002), median [IQR] length of hospital stay (41 [36 to 51] vs. 37 [32 to 49] h, P = 0.032) and median [IQR] opioid consumption (52 [35 to 73] vs. 0 [0 to 0] mg, P < 0.001). CONCLUSIONS: Implementing ITM for caesarean delivery resulted in moderate improvements in obstetric recovery and reduced opioid consumption. Cautious interpretation is warranted given the nonrandomised design of this implementation study. Our findings support the use of ITM in a multimodal analgesia strategy for patients undergoing caesarean delivery.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. van den Bosch OFC, Rijsdijk M, Rosier SE, et al. The implementation of intrathecal morphine for caesarean delivery into clinical practice, and assessment of its impact on patient-reported quality of recovery using the ObsQoR-10-Dutch scale: A single-centre cohort study. Eur J Anaesthesiol. 2025. PMID: 39881592. doi:10.1097/EJA.0000000000002127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。